Dr. Shields is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 Walnut St
Ste 1440
Philadelphia, PA 19107Phone+1 215-928-3105Fax+1 215-928-1140
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1988 - 1989
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1984 - 1988
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1984 - 1987
- UPMC Medical Education (Mercy)Internship, Transitional Year, 1983 - 1984
- University of Pittsburgh School of MedicineClass of 1983
Certifications & Licensure
- DC State Medical License Current
- DE State Medical License Current
- NY State Medical License 1995 - 2026
- NJ State Medical License 1985 - 2025
- PA State Medical License 1984 - 2024
- MD State Medical License 2018 - 2023
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- Philadelphia Magazine Castle Connolly, 2005-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema Start of enrollment: 2004 Nov 01
- Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy Start of enrollment: 2007 Apr 01
- A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma Start of enrollment: 2009 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsHIGH-RISK INTRAOCULAR RETINOBLASTOMA: Comparison Between Asian Indians and Americans From Two Major Referral Centers.Swathi Kaliki, Carol L. Shields, Ralph C. Eagle, Sadiya Iram, Jerry A. Shields
Retina. 2017-08-01 - 32 citationsLong-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centreCarol L. Shields, Zeynep Bas, Sameeksha Tadepalli, Lauren A Dalvin, Raksha Rao
The British Journal of Ophthalmology. 2020-02-12 - 118 citationsRetinoblastoma.Helen Dimaras, Timothy W Corson, David Cobrinik, Abby White, Junyang Zhao
Nature Reviews. Disease Primers. 2015-08-27
Journal Articles
- Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients with Small Choroidal Melanoma Managed by Plaque RadiotherapyLydia Komarnicky, Arman Mashayekhi, Carol L Shields, Laura E Barna, Jerry A Shields, JAMA
- Comparison of Posterior Lamellar Resection Versus Lumpectomy for Initial Management of Localized Tarsal Conjunctival Sebaceous Carcinoma in 54 CasesJerry A Shields, Carol L Shields, Sara E Lally, Indian Journal of Ophthalmology
Press Mentions
- Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye CancerOctober 21st, 2024
- IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib and Successful FDA Type C Meeting on Registrational Trial Design for Regulatory Approval in Neoadjuvant Uveal MelanomaSeptember 23rd, 2024
- IDEAYA Announces Darovasertib Phase 2 Initiation in Neoadjuvant and Adjuvant Uveal Melanoma and Guidance for Clinical Data Update in Metastatic Uveal MelanomaJanuary 23rd, 2023
- Join now to see all
Professional Memberships
- Fellow
External Links
- http://www.fighteyecancer.comhttp://www.fighteyecancer.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: